Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank45
3Y CAGR-33.3%
5Y CAGR-0.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-33.3%/yr
vs +72.7%/yr prior
5Y CAGR
-0.6%/yr
Recent deceleration
Acceleration
-106.0pp
Decelerating
Percentile
P45
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $155.46M | -17.8% |
| 2024 | $189.18M | -16.6% |
| 2023 | $226.75M | -56.7% |
| 2022 | $523.51M | +324.2% |
| 2021 | $123.41M | -22.9% |
| 2020 | $160.02M | +179.6% |
| 2019 | $57.23M | -2.8% |
| 2018 | $58.86M | -82.7% |
| 2017 | $340.68M | +24.8% |
| 2016 | $273.06M | - |